Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 20/20 | 0.69 |
| ▸ | PPARA | Q07869 | 2/20 | 0.69 |
| ▸ | PPARD | Q03181 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2786614 | 1.00 | PPARG (0.69) | PPARGPPARAPPARD | |
| SCHEMBL2786740 | 0.96 | PPARG (0.70) | PPARGPPARAPPARD | |
| SCHEMBL2787381 | 0.95 | PPARG (0.72) | PPARGPPARA | |
| SCHEMBL2787218 | 0.95 | PPARG (0.72) | PPARGPPARAPPARD | |
| SCHEMBL2786236 | 0.93 | PPARG (0.62) | PPARGPPARA | |
| SCHEMBL7923107 | 0.93 | PPARG (0.62) | PPARGPPARAPPARD | |
| SCHEMBL7922713 | 0.93 | PPARG (0.62) | PPARGPPARAPPARD | |
| SCHEMBL2834833 | 0.92 | PPARG (0.73) | PPARGPPARA | |
| SCHEMBL2786970 | 0.91 | PPARG (0.71) | PPARGPPARA | |
| SCHEMBL2785285 | 0.91 | PPARG (0.72) | PPARGPPARAPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020137794-A1 | Retinoic acid receptor (RAR) agonists, agonists for steroid/thyroid hormone receptor superfamily, and an agonist for a heterodimer partner | SALK INSTITUTE FOR BIOLOGICAL STUDIES, THE | 2002-09-26 | — | — | US | claimed |
| US-6436993-B1 | SYNERGISTIC MIXTURES OF RETINOIC ACID RECEPTOR (RAR) ANTAGONISTS AND STEROID, THYROID OR RETINOID RECEPTOR AGONISTS SUCH AS PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS USED TO CONTROL CELLULAR PROCESSES | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES | 2002-08-20 | — | — | US | claimed |
| US-6294580-B1 | FOR THERAPY AND PROPHYLAXIS OF TYPE II OR NON-INSULIN DEPENDENT DIABETES MELLITUS, HYPERGLYCAEMIA, DYSLIPIDEMIA, TYPE II DIABETES, TYPE I DIABETES, HYPERTRIGLYCERIDEMIA, SYNDROME X, INSULIN RESISTANCE, HEART FAILURE | GLAXO WELLCOME INC. | 2001-09-25 | — | — | US | claimed |
| EP-0888317-B1 | SUBSTITUTED 4-HYDROXY-PHENYLALCANOIC ACID DERIVATIVES WITH AGONIST ACTIVITY TO PPAR-GAMMA | GLAXO GROUP LTD (GB) | 2001-09-12 | — | — | EP | claimed |
| WO-2001003659-A1 | USE OF RAR ANTAGONISTS AS MODULATORS OF HORMONE MEDIATED PROCESSES | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2001-01-18 | — | — | WO | claimed |
| EP-2081599-A2 | COMPOUNDS, KITS AND METHODS FOR CONFERRING CYTOPROTECTION | University of Debrecen (HU) | 2009-07-29 | — | — | EP | disclosed |
| US-20090155228-A1 | COMPOUNDS, KITS AND METHODS FOR CONFERRING CYTOPROTECTION | UNIVERSITY OF DEBRECEN (HU) | 2009-06-18 | — | — | US | disclosed |
| WO-2007144679-A2 | COMPOUNDS, KITS AND METHODS FOR CONFERRING CYTOPROTECTION | UNIVERSITY OF DEBRECEN (HU) | 2007-12-21 | — | — | WO | disclosed |
| US-20020137794-A1 | Retinoic acid receptor (RAR) agonists, agonists for steroid/thyroid hormone receptor superfamily, and an agonist for a heterodimer partner | SALK INSTITUTE FOR BIOLOGICAL STUDIES, THE | 2002-09-26 | — | — | US | disclosed |
| US-6436993-B1 | SYNERGISTIC MIXTURES OF RETINOIC ACID RECEPTOR (RAR) ANTAGONISTS AND STEROID, THYROID OR RETINOID RECEPTOR AGONISTS SUCH AS PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS USED TO CONTROL CELLULAR PROCESSES | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES | 2002-08-20 | — | — | US | disclosed |
| US-6294580-B1 | FOR THERAPY AND PROPHYLAXIS OF TYPE II OR NON-INSULIN DEPENDENT DIABETES MELLITUS, HYPERGLYCAEMIA, DYSLIPIDEMIA, TYPE II DIABETES, TYPE I DIABETES, HYPERTRIGLYCERIDEMIA, SYNDROME X, INSULIN RESISTANCE, HEART FAILURE | GLAXO WELLCOME INC. | 2001-09-25 | — | — | US | disclosed |
| EP-0888317-B1 | SUBSTITUTED 4-HYDROXY-PHENYLALCANOIC ACID DERIVATIVES WITH AGONIST ACTIVITY TO PPAR-GAMMA | GLAXO GROUP LTD (GB) | 2001-09-12 | — | — | EP | disclosed |
| WO-2001003659-A1 | USE OF RAR ANTAGONISTS AS MODULATORS OF HORMONE MEDIATED PROCESSES | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2001-01-18 | — | — | WO | disclosed |
| EP-0888317-A1 | SUBSTITUTED 4-HYDROXY-PHENYLALCANOIC ACID DERIVATIVES WITH AGONIST ACTIVITY TO PPAR-GAMMA | GLAXO GROUP LIMITED (GB) | 1999-01-07 | — | — | EP | disclosed |
| WO-1997031907-A1 | SUBSTITUTED 4-HYDROXY-PHENYLALCANOIC ACID DERIVATIVES WITH AGONIST ACTIVITY TO PPAR-GAMMA | GLAXO GROUP LIMITED (GB) | 1997-09-04 | — | — | WO | disclosed |